ISRCTN10271810进行中（未招募）1 期
Phase I trial, CRO code: 21-013 [The full scientific title will be published within 30 months after the end of the trial]
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended.
排除标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended.
研究者
相似试验
进行中（未招募）
1 期
Phase I trial - 2021-006930-37The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has endedISRCTN15751828Omeros Corporation (United States)12
进行中（未招募）
1 期
Phase I trial; HMR code: 24-003Healthy volunteersISRCTN16055614Sling Therapeutics, Inc.20
已完成
1 期
Phase I trial, HMR code: 21-014The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN58651193Silence Therapeutics (United Kingdom)32
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-001Healthy volunteersISRCTN15245786Medherant Limited24
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-011Healthy volunteersISRCTN17328380Asceneuron (Switzerland)16